毒素対抗毒素RNAペアはCRISPR-Casシステムを保護する
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
PubMedで要約を見る
まとめ
この要約は機械生成です。CRISPR-Casシステムは 毒素-抗毒素RNAペアであるCreTAを用いて 自身の免疫を調節します このシステムは細胞をCRISPR-Casに依存させ,Casタンパク質の新たな機能を明らかにします.
科学分野
- 微生物学
- 分子生物学
- 遺伝学
背景
- CRISPR-Casシステムは,プロカリオットの適応免疫を提供します.
- マルチサブユニットCRISPRエフェクターカスケードは,遺伝子発現を調節する役割を果たします.
研究 の 目的
- 毒素-抗毒素RNAペアのCRISPR-Casエフェクターカスケードの調節作用を調査する.
- カスケードがCreTAシステムと相互作用するメカニズムを解明する.
- この相互作用がCRISPR- Casの免疫と遺伝子調節に及ぼす影響を調査する.
主な方法
- RNAのシーケンシングと分析
- 遺伝子発現分析
- CRISPR-Casシステムの特徴
- 様々なCRISPR-CasロシにおけるCreTAアナログの識別
主要な成果
- カスケード・トランスクリプションは,毒素-抗毒素RNAペアCreTAを調節する.
- CreT毒素はアルギニン tRNAを隔離し,CreA抗毒素は成熟のためにCas6を必要とします.
- クレートプロモーターとの相互作用により,クレート転写を抑制する.
- クレータ欠乏細胞は,転移可能な要素に対するカスケード遺伝子の感受性の増加を示します.
- クレータの類型は様々な古生物および細菌のCRISPR- Casロシで確認された.
結論
- 毒素- 抗毒素RNAペアは,CRISPR- Casへの細胞依存を誘発することによって,CRISPR免疫を保護する.
- この研究は,Casタンパク質の多機能性とCRISPR-Casの規制メカニズムの複雑さを強調しています.
関連する概念動画
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...